Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which proceeds slowly and cannot be ...
People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions in their ...
News Medical on MSN3d
New compound HPH-15 offers promising alternative to diabetes medicationsKumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and ...
Diabetes researchers and bioinformaticians from the Icahn School of Medicine at Mount Sinai have developed a new ...
Type 2 diabetes is a common condition where the body either doesn’t use insulin effectively or doesn’t produce enough of it, ...
This research marks a vital step towards innovative therapies, bringing new hope to millions affected by diabetes worldwide. ...
People with diabetes who are taking GLP-1 meds such as Ozempic or Mounjaro may be getting an added bonus: Reductions ...
New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney failure in the world - that could see patients treated with new gene and drug ...
Eli Lilly, the US pharmaceutical giant that gained widespread attention globally with its weight-loss treatments, plans to ...
Dr Miriam Stoppard on the news that a white blood cell, involved in battling infections, could cause type 1 diabetes, but ...
Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 ...
A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback